Immunotherapy Gets 'Meaningful' Survival Win in Operable Gastric Cancer

(MedPage Today) — BERLIN — In a global phase III trial, the addition of durvalumab (Imfinzi) to standard chemotherapy given before and after surgery led to a statistically significant and “clinically meaningful” improvement in patient survival…